logo

CTKB

Cytek Biosciences·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
5.12 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is CTKB a Good Buy Right Now?
  • Based on a composite score of 5.12/10, we rate CTKB as a Netural. Our analysis breaks down into 9.60/10 for Fundamentals, 3.44/10 for Technicals, and 3.72/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CTKB undervalued or overvalued?
Technical Analysis of CTKB?
Is money flowing into or out of CTKB?